GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $10.70 $12.70 Thursday, 18th Apr 2024 KALV stock ended at $11.50. This is 1.29% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 4.17% from a day low at $11.28 to a day high of $11.75.
90 days $10.70 $16.88
52 weeks $7.21 $16.88

Historical KalVista Pharmaceuticals Inc prices

Date Open High Low Close Volume
2024-04-18 $11.53 $11.75 $11.28 $11.50 398 487
2024-04-17 $11.80 $11.94 $11.65 $11.65 288 709
2024-04-16 $11.53 $12.16 $11.48 $11.88 486 797
2024-04-15 $11.82 $12.01 $11.50 $11.74 304 354
2024-04-12 $11.88 $12.05 $11.70 $11.89 237 801
2024-04-11 $11.87 $12.26 $11.71 $12.10 296 385
2024-04-10 $11.72 $11.94 $11.37 $11.93 519 188
2024-04-09 $11.09 $11.85 $11.02 $11.81 570 267
2024-04-08 $11.11 $11.20 $10.82 $11.04 203 169
2024-04-05 $11.13 $11.38 $10.97 $11.09 182 657
2024-04-04 $11.30 $11.40 $10.95 $11.21 492 997
2024-04-03 $11.01 $11.34 $10.81 $11.26 214 265
2024-04-02 $11.15 $11.48 $10.92 $11.04 1 461 162
2024-04-01 $11.77 $11.79 $11.03 $11.40 817 261
2024-03-28 $11.08 $12.46 $10.92 $11.86 2 152 834
2024-03-27 $11.20 $11.41 $10.97 $11.07 259 963
2024-03-26 $11.22 $11.38 $10.70 $11.11 516 722
2024-03-25 $11.74 $11.84 $11.04 $11.13 502 806
2024-03-22 $12.17 $12.29 $11.75 $11.85 261 701
2024-03-21 $12.30 $12.70 $12.07 $12.15 269 484
2024-03-20 $12.00 $12.24 $11.75 $12.23 440 609
2024-03-19 $11.87 $12.36 $11.65 $11.84 449 152
2024-03-18 $11.92 $12.35 $11.70 $11.99 535 992
2024-03-15 $12.42 $12.56 $11.87 $11.93 727 031
2024-03-14 $12.42 $12.57 $12.12 $12.43 454 926
Click to get the best stock tips daily for free!

About KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed ... KALV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT